Latest Galantamine Stories
A new study shows cognitive enhancement drugs do not improve cognition or brain function, and may actually cause adverse health effects in people with mild cognitive impairment.
Scientists at the Virginia Tech Carilion Research Institute have discovered how the predominant class of Alzheimer's pharmaceuticals might sharpen the brain's performance.
A review of research evidence produced by researchers from the Peninsula Technology Assessment Group, part of the Peninsula College of Medicine and Dentistry, has played a pivotal role in the decision by the National Institute for Health and Clinical Excellence (NICE) to extend the availability of donepezil, galantamine, rivastigmine and memantine for Alzheimer's disease announced today (18th January 2011).
New study finds that older people hospitalized for bradycardia are more likely to be taking cholinesterase-inhibiting drugs such as donepezil.
COLUMBUS, Ohio, Aug. 24 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the availability of Galantamine Hyrdrobromide Oral Solution, 4mg/mL as of August 14, 2009.
CORONA, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.
TITUSVILLE, N.J., Aug. 28 /PRNewswire/ -- Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced that it will appeal yesterday's decision by the U.S. District Court of Delaware, which ruled the patent for RAZADYNE(R) (galantamine hydrobromide) is invalid.
Forest Laboratories has presented positive Phase III data of a once-daily extended-release formulation of Namenda for Alzheimer's disease.
- A trick or prank.